Piet van der Graaf, PharmD, PhD 现任 Certara 公司应用生物模拟高级副总裁,莱顿大学系统药理学教授,以及辛辛那提儿童医院医疗中心儿科教授。Previously, he was the Director of the Leiden Academic Centre for Drug Research and held leadership positions at Pfizer in Discovery Biology, DMPK and Clinical Pharmacology. Piet 于Pharmacometrics & Systems Pharmacology before becoming Editor-in-Chief of Clinical Pharmacology & Therapeutics. Piet 曾在伦敦国王学院师从诺贝尔奖获得者 Sir James Black,接受了临床医学的博士培训。He was awarded the 2024 Gary Neil Prize for Innovation in Drug Development from the American Society of Clinical Pharmacology and Therapeutics (ASCPT) and the 2021 Leadership Award from the International Society of Pharmacometrics (ISoP). Piet 是英国药理学会的当选委员,在定量药理学和药物开发领域发表了超过 250 篇同行评议的论文。
Piet van der Graaf
Senior Vice President and Head of Quantitative Systems Pharmacology
相关资源
Integrated mechanistic modeling approaches in oncology drug development
网络研讨会
The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors
网络研讨会点播
机制性 MIDD:凭借坚实的科学基础实现监管成功
现场活动
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators
网络研讨会点播
Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations
网络研讨会点播
Start right, finish strong: 抗体-药物偶联物(ADC)研究成功之道
网络研讨会点播
CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access
网络研讨会
Virtual triplets: The next step in personalized and ethical drug development
博客
